- Home
- TNGX vs GRRRW Comparison
TNGX vs GRRRW Comparison
Compare TNGX & GRRRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- GRRRW
- Stock Information
- Founded
- TNGX 2014
- GRRRW N/A
- Country
- TNGX United States
- GRRRW United Kingdom
- Employees
- TNGX N/A
- GRRRW 143
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- GRRRW Computer Software: Prepackaged Software
- Sector
- TNGX Health Care
- GRRRW Technology
- Exchange
- TNGX Nasdaq
- GRRRW Nasdaq
- Market Cap
- TNGX 723.2M
- GRRRW N/A
- IPO Year
- TNGX N/A
- GRRRW N/A
- Fundamental
- Price
- TNGX $7.88
- GRRRW $0.58
- Analyst Decision
- TNGX Strong Buy
- GRRRW
- Analyst Count
- TNGX 6
- GRRRW 0
- Target Price
- TNGX $10.00
- GRRRW N/A
- AVG Volume (30 Days)
- TNGX 1.5M
- GRRRW 336.7K
- Earning Date
- TNGX 11-05-2025
- GRRRW 04-04-2025
- Dividend Yield
- TNGX N/A
- GRRRW N/A
- EPS Growth
- TNGX N/A
- GRRRW N/A
- EPS
- TNGX N/A
- GRRRW 2.28
- Revenue
- TNGX $24,296,000.00
- GRRRW $78,940,347.00
- Revenue This Year
- TNGX $20.42
- GRRRW N/A
- Revenue Next Year
- TNGX N/A
- GRRRW N/A
- P/E Ratio
- TNGX N/A
- GRRRW $25.04
- Revenue Growth
- TNGX N/A
- GRRRW 424.97
- 52 Week Low
- TNGX $1.03
- GRRRW $1.06
- 52 Week High
- TNGX $10.81
- GRRRW $1.54
- Technical
- Relative Strength Index (RSI)
- TNGX 66.61
- GRRRW N/A
- Support Level
- TNGX $6.38
- GRRRW N/A
- Resistance Level
- TNGX $6.90
- GRRRW N/A
- Average True Range (ATR)
- TNGX 0.45
- GRRRW 0.00
- MACD
- TNGX 0.06
- GRRRW 0.00
- Stochastic Oscillator
- TNGX 95.88
- GRRRW 0.00
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About GRRRW Gorilla Technology Group Inc. Warrant
Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.